Global and China Antiparasitic Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 125 pages | ID: G99B68F6B072EN
QYResearch

Abstracts

Global Antiparasitic Drugs Scope and Market Size
Antiparasitic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiparasitic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• by Type
• Anthelmintics
• Antiprotozoals
• Others
• by Delivery Type
• Oral
• Injectable
• Topical

Market segment by Application, split into

• Hospital
• Clinic
• Others

Based on regional and country-level analysis, the Antiparasitic Drugs market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Antiparasitic Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Ipca Laboratories Ltd
• Zydus Cadila
• Merck
• Pfizer
• GlaxoSmithKline Plc.
• Cipla Ltd
• Ranbaxy Laboratories
• Novartis AG
• Alvizia Health Care
• Bayer AG
• Roche Inc
• Arbor Pharmaceuticals Inc.
• Sanofi
• AstraZeneca
• Alkem Laboratories Limited

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Anthelmintics
  1.2.3 Antiprotozoals
  1.2.4 Others
1.3 Market by Application
  1.3.1 Global Antiparasitic Drugs Market Share by Application: 2020 VS 2026
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Antiparasitic Drugs Market Perspective (2015-2026)
2.2 Global Antiparasitic Drugs Growth Trends by Regions
  2.2.1 Antiparasitic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antiparasitic Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Antiparasitic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antiparasitic Drugs Players by Market Size
  3.1.1 Global Top Antiparasitic Drugs Players by Revenue (2015-2020)
  3.1.2 Global Antiparasitic Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiparasitic Drugs Revenue
3.4 Global Antiparasitic Drugs Market Concentration Ratio
  3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2019
3.5 Key Players Antiparasitic Drugs Area Served
3.6 Key Players Antiparasitic Drugs Product Solution and Service
3.7 Date of Enter into Antiparasitic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ANTIPARASITIC DRUGS BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antiparasitic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Antiparasitic Drugs Forecasted Market Size by Type (2021-2026)

5 ANTIPARASITIC DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antiparasitic Drugs Historic Market Size by Application (2015-2020)
5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antiparasitic Drugs Market Size (2015-2026)
6.2 North America Antiparasitic Drugs Market Size by Type (2015-2020)
6.3 North America Antiparasitic Drugs Market Size by Application (2015-2020)
6.4 North America Antiparasitic Drugs Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Antiparasitic Drugs Market Size (2015-2026)
7.2 Europe Antiparasitic Drugs Market Size by Type (2015-2020)
7.3 Europe Antiparasitic Drugs Market Size by Application (2015-2020)
7.4 Europe Antiparasitic Drugs Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Antiparasitic Drugs Market Size (2015-2026)
8.2 China Antiparasitic Drugs Market Size by Type (2015-2020)
8.3 China Antiparasitic Drugs Market Size by Application (2015-2020)
8.4 China Antiparasitic Drugs Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Antiparasitic Drugs Market Size (2015-2026)
9.2 Japan Antiparasitic Drugs Market Size by Type (2015-2020)
9.3 Japan Antiparasitic Drugs Market Size by Application (2015-2020)
9.4 Japan Antiparasitic Drugs Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Antiparasitic Drugs Market Size (2015-2026)
10.2 Southeast Asia Antiparasitic Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Antiparasitic Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Antiparasitic Drugs Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11KEY PLAYERS PROFILES

11.1 Ipca Laboratories Ltd
  11.1.1 Ipca Laboratories Ltd Company Details
  11.1.2 Ipca Laboratories Ltd Business Overview
  11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Introduction
  11.1.4 Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2015-2020))
  11.1.5 Ipca Laboratories Ltd Recent Development
11.2 Zydus Cadila
  11.2.1 Zydus Cadila Company Details
  11.2.2 Zydus Cadila Business Overview
  11.2.3 Zydus Cadila Antiparasitic Drugs Introduction
  11.2.4 Zydus Cadila Revenue in Antiparasitic Drugs Business (2015-2020)
  11.2.5 Zydus Cadila Recent Development
11.3 Merck
  11.3.1 Merck Company Details
  11.3.2 Merck Business Overview
  11.3.3 Merck Antiparasitic Drugs Introduction
  11.3.4 Merck Revenue in Antiparasitic Drugs Business (2015-2020)
  11.3.5 Merck Recent Development
11.4 Pfizer
  11.4.1 Pfizer Company Details
  11.4.2 Pfizer Business Overview
  11.4.3 Pfizer Antiparasitic Drugs Introduction
  11.4.4 Pfizer Revenue in Antiparasitic Drugs Business (2015-2020)
  11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline Plc.
  11.5.1 GlaxoSmithKline Plc. Company Details
  11.5.2 GlaxoSmithKline Plc. Business Overview
  11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Introduction
  11.5.4 GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2015-2020)
  11.5.5 GlaxoSmithKline Plc. Recent Development
11.6 Cipla Ltd
  11.6.1 Cipla Ltd Company Details
  11.6.2 Cipla Ltd Business Overview
  11.6.3 Cipla Ltd Antiparasitic Drugs Introduction
  11.6.4 Cipla Ltd Revenue in Antiparasitic Drugs Business (2015-2020)
  11.6.5 Cipla Ltd Recent Development
11.7 Ranbaxy Laboratories
  11.7.1 Ranbaxy Laboratories Company Details
  11.7.2 Ranbaxy Laboratories Business Overview
  11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Introduction
  11.7.4 Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2015-2020)
  11.7.5 Ranbaxy Laboratories Recent Development
11.8 Novartis AG
  11.8.1 Novartis AG Company Details
  11.8.2 Novartis AG Business Overview
  11.8.3 Novartis AG Antiparasitic Drugs Introduction
  11.8.4 Novartis AG Revenue in Antiparasitic Drugs Business (2015-2020)
  11.8.5 Novartis AG Recent Development
11.9 Alvizia Health Care
  11.9.1 Alvizia Health Care Company Details
  11.9.2 Alvizia Health Care Business Overview
  11.9.3 Alvizia Health Care Antiparasitic Drugs Introduction
  11.9.4 Alvizia Health Care Revenue in Antiparasitic Drugs Business (2015-2020)
  11.9.5 Alvizia Health Care Recent Development
11.10 Bayer AG
  11.10.1 Bayer AG Company Details
  11.10.2 Bayer AG Business Overview
  11.10.3 Bayer AG Antiparasitic Drugs Introduction
  11.10.4 Bayer AG Revenue in Antiparasitic Drugs Business (2015-2020)
  11.10.5 Bayer AG Recent Development
11.11 Roche Inc
  10.11.1 Roche Inc Company Details
  10.11.2 Roche Inc Business Overview
  10.11.3 Roche Inc Antiparasitic Drugs Introduction
  10.11.4 Roche Inc Revenue in Antiparasitic Drugs Business (2015-2020)
  10.11.5 Roche Inc Recent Development
11.12 Arbor Pharmaceuticals Inc.
  10.12.1 Arbor Pharmaceuticals Inc. Company Details
  10.12.2 Arbor Pharmaceuticals Inc. Business Overview
  10.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Introduction
  10.12.4 Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2015-2020)
  10.12.5 Arbor Pharmaceuticals Inc. Recent Development
11.13 Sanofi
  10.13.1 Sanofi Company Details
  10.13.2 Sanofi Business Overview
  10.13.3 Sanofi Antiparasitic Drugs Introduction
  10.13.4 Sanofi Revenue in Antiparasitic Drugs Business (2015-2020)
  10.13.5 Sanofi Recent Development
11.14 AstraZeneca
  10.14.1 AstraZeneca Company Details
  10.14.2 AstraZeneca Business Overview
  10.14.3 AstraZeneca Antiparasitic Drugs Introduction
  10.14.4 AstraZeneca Revenue in Antiparasitic Drugs Business (2015-2020)
  10.14.5 AstraZeneca Recent Development
11.15 Alkem Laboratories Limited
  10.15.1 Alkem Laboratories Limited Company Details
  10.15.2 Alkem Laboratories Limited Business Overview
  10.15.3 Alkem Laboratories Limited Antiparasitic Drugs Introduction
  10.15.4 Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2015-2020)
  10.15.5 Alkem Laboratories Limited Recent Development

12ANALYST'S VIEWPOINTS/CONCLUSIONS

13APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Antiparasitic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Anthelmintics
Table 4. Key Players of Antiprotozoals
Table 5. Key Players of Others
Table 6. Global Antiparasitic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Antiparasitic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Antiparasitic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Antiparasitic Drugs Market Share by Regions (2015-2020)
Table 10. Global Antiparasitic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Antiparasitic Drugs Market Share by Regions (2021-2026)
Table 12. Antiparasitic Drugs Market Market Trends
Table 13. Antiparasitic Drugs Market Drivers
Table 14. Antiparasitic Drugs Market Challenges
Table 15. Antiparasitic Drugs Market Restraints
Table 16. Global Antiparasitic Drugs Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Antiparasitic Drugs Market Share by Players (2015-2020)
Table 18. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiparasitic Drugs as of 2019)
Table 19. Global Antiparasitic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antiparasitic Drugs Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antiparasitic Drugs Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Antiparasitic Drugs Market Size Share by Type (2015-2020)
Table 25. Global Antiparasitic Drugs Revenue Market Share by Type (2021-2026)
Table 26. Global Antiparasitic Drugs Market Size Share by Application (2015-2020)
Table 27. Global Antiparasitic Drugs Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Antiparasitic Drugs Market Size Share by Application (2021-2026)
Table 29. North America Antiparasitic Drugs Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Antiparasitic Drugs Market Share by Type (2015-2020)
Table 31. North America Antiparasitic Drugs Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Antiparasitic Drugs Market Share by Application (2015-2020)
Table 33. North America Antiparasitic Drugs Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Antiparasitic Drugs Market Share by Country (2015-2020)
Table 35. Europe Antiparasitic Drugs Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Antiparasitic Drugs Market Share by Type (2015-2020)
Table 37. Europe Antiparasitic Drugs Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Antiparasitic Drugs Market Share by Application (2015-2020)
Table 39. Europe Antiparasitic Drugs Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Antiparasitic Drugs Market Share by Country (2015-2020)
Table 41. China Antiparasitic Drugs Market Size by Type (2015-2020) (US$ Million)
Table 42. China Antiparasitic Drugs Market Share by Type (2015-2020)
Table 43. China Antiparasitic Drugs Market Size by Application (2015-2020) (US$ Million)
Table 44. China Antiparasitic Drugs Market Share by Application (2015-2020)
Table 45. China Antiparasitic Drugs Market Size by Region (US$ Million) (2015-2020)
Table 46. China Antiparasitic Drugs Market Share by Region (2015-2020)
Table 47. Japan Antiparasitic Drugs Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Antiparasitic Drugs Market Share by Type (2015-2020)
Table 49. Japan Antiparasitic Drugs Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Antiparasitic Drugs Market Share by Application (2015-2020)
Table 51. Japan Antiparasitic Drugs Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Antiparasitic Drugs Market Share by Country (2015-2020)
Table 53. Southeast Asia Antiparasitic Drugs Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Antiparasitic Drugs Market Share by Type (2015-2020)
Table 55. Southeast Asia Antiparasitic Drugs Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Antiparasitic Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Antiparasitic Drugs Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Antiparasitic Drugs Market Share by Country (2015-2020)
Table 59. Ipca Laboratories Ltd Company Details
Table 60. Ipca Laboratories Ltd Business Overview
Table 61. Ipca Laboratories Ltd Product
Table 62. Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 63. Ipca Laboratories Ltd Recent Development
Table 64. Zydus Cadila Company Details
Table 65. Zydus Cadila Business Overview
Table 66. Zydus Cadila Product
Table 67. Zydus Cadila Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 68. Zydus Cadila Recent Development
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Product
Table 72. Merck Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 73. Merck Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 78. Pfizer Recent Development
Table 79. GlaxoSmithKline Plc. Company Details
Table 80. GlaxoSmithKline Plc. Business Overview
Table 81. GlaxoSmithKline Plc. Product
Table 82. GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 83. GlaxoSmithKline Plc. Recent Development
Table 84. Cipla Ltd Company Details
Table 85. Cipla Ltd Business Overview
Table 86. Cipla Ltd Product
Table 87. Cipla Ltd Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 88. Cipla Ltd Recent Development
Table 89. Ranbaxy Laboratories Company Details
Table 90. Ranbaxy Laboratories Business Overview
Table 91. Ranbaxy Laboratories Product
Table 92. Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 93. Ranbaxy Laboratories Recent Development
Table 94. Novartis AG Business Overview
Table 95. Novartis AG Product
Table 96. Novartis AG Company Details
Table 97. Novartis AG Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 98. Novartis AG Recent Development
Table 99. Alvizia Health Care Company Details
Table 100. Alvizia Health Care Business Overview
Table 101. Alvizia Health Care Product
Table 102. Alvizia Health Care Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 103. Alvizia Health Care Recent Development
Table 104. Bayer AG Company Details
Table 105. Bayer AG Business Overview
Table 106. Bayer AG Product
Table 107. Bayer AG Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 108. Bayer AG Recent Development
Table 109. Roche Inc Company Details
Table 110. Roche Inc Business Overview
Table 111. Roche Inc Product
Table 112. Roche Inc Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 113. Roche Inc Recent Development
Table 114. Arbor Pharmaceuticals Inc. Company Details
Table 115. Arbor Pharmaceuticals Inc. Business Overview
Table 116. Arbor Pharmaceuticals Inc. Product
Table 117. Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 118. Arbor Pharmaceuticals Inc. Recent Development
Table 119. Sanofi Company Details
Table 120. Sanofi Business Overview
Table 121. Sanofi Product
Table 122. Sanofi Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 123. Sanofi Recent Development
Table 124. AstraZeneca Company Details
Table 125. AstraZeneca Business Overview
Table 126. AstraZeneca Product
Table 127. AstraZeneca Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 128. AstraZeneca Recent Development
Table 129. Alkem Laboratories Limited Company Details
Table 130. Alkem Laboratories Limited Business Overview
Table 131. Alkem Laboratories Limited Product
Table 132. Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2015-2020) (US$ Million)
Table 133. Alkem Laboratories Limited Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antiparasitic Drugs Market Share by Type: 2020 VS 2026
Figure 2. Anthelmintics Features
Figure 3. Antiprotozoals Features
Figure 4. Others Features
Figure 5. Global Antiparasitic Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Antiparasitic Drugs Report Years Considered
Figure 10. Global Antiparasitic Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Antiparasitic Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Antiparasitic Drugs Market Share by Regions (2021-2026)
Figure 13. Global Antiparasitic Drugs Market Share by Players in 2019
Figure 14. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiparasitic Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2019
Figure 16. North America Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Antiparasitic Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Ipca Laboratories Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 44. Zydus Cadila Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 45. Merck Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 46. Pfizer Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 47. GlaxoSmithKline Plc. Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 48. Cipla Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 49. Ranbaxy Laboratories Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 50. Novartis AG Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 51. Alvizia Health Care Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 52. Bayer AG Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 53. Roche Inc Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 54. Arbor Pharmaceuticals Inc. Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 55. Sanofi Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 56. AstraZeneca Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 57. Alkem Laboratories Limited Revenue Growth Rate in Antiparasitic Drugs Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed